Skip to main content
Premium Trial:

Request an Annual Quote

Varmus Means Business

Speaking to National Cancer Institute staffers this week, Harold Varmus — the agency's newly installed director — "said he plans to review all NCI programs, address 'dysfunction,' and come up with a list of big questions that block progress against cancer," Science Insider reports. Specifically, Varmus "will begin by overhauling NCI's cooperative clinical trials system, making greater use of NIH's clinical center, and working on ways to speed cancer drug approvals," according to Science. He also said that "he will be 'strenuous in my insistence' about ensuring access to data, research materials, and publications," Science reports. Varmus also told attendees not to expect "budget magic." Science Insider adds that Douglas Lowy will serve as Varmus' deputy director when Anna Barker, deputy director under former NCI director John Niederhuber, leaves her post in August.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.